Golcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT07578077 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07578077
- Sponsor
- City of Hope Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-21
- Primary completion
- 2030-04-21
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.